Literature DB >> 871458

Sixteen months' experience with 140 posterior chamber intraocular lens implants.

J L Pearce.   

Abstract

Three main designs of posterior chamber lenses in 140 cases have been reviewed. The visual results are satisfactory; patient satisfaction is good; and postoperative complications are limited to anterior dislocation of the feet of the lens and the necessity to wash out cortical remnants from behind the prosthesis in a small percentage of cases. The posterior chamber prosthesis is free from some of the complications of other intraocular lenses and probably provides the most 'normal' looking eye of any pseudophakoi.

Entities:  

Mesh:

Year:  1977        PMID: 871458      PMCID: PMC1042958          DOI: 10.1136/bjo.61.5.310

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

1.  Long-term results of the Choyce anterior chamber lens implants Marks V, VII, and VIII.

Authors:  J L Pearce
Journal:  Br J Ophthalmol       Date:  1975-02       Impact factor: 4.638

2.  Intra-ocularacrylic lenses. 10 years' development.

Authors:  H RIDLEY
Journal:  Br J Ophthalmol       Date:  1960-12       Impact factor: 4.638

3.  Cataract surgery with particular reference to intra-ocular lenticular implants of various types.

Authors:  H RIDLEY
Journal:  Trans Ophthalmol Soc U K       Date:  1958

4.  Further experiences of intra-ocular acrylic lens surgery; with a report of more than 100 cases.

Authors:  H RIDLEY
Journal:  Br J Ophthalmol       Date:  1954-03       Impact factor: 4.638

5.  Further observations on intraocular acrylic lenses in cataract surgery.

Authors:  H RIDLEY
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1953 Jan-Feb

6.  New lightweight sutured posterior chamber lens implant.

Authors:  J L Pearce
Journal:  Trans Ophthalmol Soc U K       Date:  1976-04

7.  Perifoveal vascular leakage and macular oedema after intracapsular cataract extraction.

Authors:  T A Meredith; K R Kenyon; L J Singerman; S L Fine
Journal:  Br J Ophthalmol       Date:  1976-11       Impact factor: 4.638

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.